
Azenta (AZTA) Stock Forecast & Price Target
Azenta (AZTA) Analyst Ratings
Bulls say
Azenta Inc. reported an adjusted EBITDA margin of 13.0%, reflecting a year-over-year increase of 230 basis points and surpassing consensus expectations. The company anticipates gross margin improvements contributing approximately 200 basis points, alongside operational leverage expected to add around 100 basis points, which together signal strong potential for enhanced profitability. Furthermore, Azenta's growth outlook is bolstered by its Multiomics and Sample Management Solutions segments, supported by strategic expansions such as adding 20 commercial representatives, which may accelerate revenue growth and earnings over the coming years.
Bears say
Azenta Inc experienced a decline in its adjusted gross margin to 46.7%, falling short of the consensus estimate, primarily due to weaker performance in its Multiomics segment. The company's Sample Management Solutions segment reported flat organic revenue growth of $86 million, missing its target and indicating a slowdown in traction, compounded by external factors such as constrained customer budgets and impacts from government shutdowns. Consequently, the financial outlook has been adjusted downward for FY26 and FY27, reflecting expectations of lower revenue growth and potential earnings challenges amidst increased competition and operational headwinds.
This aggregate rating is based on analysts' research of Azenta and is not a guaranteed prediction by Public.com or investment advice.
Azenta (AZTA) Analyst Forecast & Price Prediction
Start investing in Azenta (AZTA)
Order type
Buy in
Order amount
Est. shares
0 shares